Astrum

Phase I clinical trial recruitment: assessing feasibility beyond database size

What does volunteer database size tell sponsors about recruitment?

A large volunteer database is useful for Phase I clinical trial recruitment, but its size alone is not enough to assess recruitment feasibility. Sponsors also need to understand how many potential participants meet the protocol requirements, are available and are willing to take part.

Susana Paixão, Clinical Trial Recruitment Manager, at Astrum’s Phase I unit in Porto, explains: “The database size is very important. It’s a starting point, but the real value comes from how well you know the volunteers and understand the population behind the numbers.”

This is particularly relevant for protocols that require specific populations, longer confinement periods, intensive monitoring or a substantial time commitment. Assessing feasibility means understanding both the protocol requirements and the people who may be able to meet them.

Expert perspective

Susana Paixão

Clinical Trial Recruitment Manager

Astrum Phase I Unit, Porto

Keeping volunteer database information up to date

A database may contain thousands of potential volunteers, but only a proportion will meet the requirements of a particular Phase I protocol. Criteria such as age range, sex, BMI, smoking status, contraceptive method, medical restrictions and previous clinical trial participation can substantially reduce the potential pool.

Potential volunteers who appear suitable may not be interested in the study, available on the required dates or able to meet its practical requirements. Participation is voluntary, and database information cannot confirm willingness to enrol.

As Paixão explains: “What matters is really how many people within that database potentially fit that specific population you’re looking for.”

Recruitment feasibility therefore depends on accurate, up-to-date volunteer information, as well as database size. Weight, smoking status, contraceptive methods and medical conditions can change after registration. Volunteers may also move or have different availability.

At Astrum’s Porto unit, the recruitment team uses every interaction with volunteers to update the relevant database information. This ongoing maintenance helps the team assess the current population rather than rely only on details recorded at registration.

Assessing Phase I recruitment feasibility early

Recruitment planning begins during study feasibility, before screening opens. At Astrum, the recruitment team reviews the main population requirements, assess the potentially available pool and draw on experience from studies with similar populations or practical demands.

“Recruitment starts earlier than most people think. We don’t wait until the recruitment officially opens to start assessing whether the planned timelines are realistic.”

This does not mean starting protocol-specific screening before the relevant approvals are in place. It means involving the recruitment team early enough to assess timeline assumptions and identify potential difficulties.

For a complex trial, the assessment considers:

Protocol requirements  target population → available pool → practical study burden → recruitment strategy

Planning also needs to account for other upcoming studies. Trials targeting similar populations may compete for the same volunteers, affecting availability and recruitment timelines. For sponsors, the aim is to assess whether suitable participants can realistically be screened and enrolled at the required pace, not simply whether a potentially eligible population exists.

Eligibility, availability and participant commitment

Long confinement periods, multiple visits, intensive monitoring and complex procedures affect whether someone can take part in a Phase I trial. Meeting the inclusion and exclusion criteria does not necessarily mean a volunteer can commit to the study schedule. “The more demanding the protocol becomes, the less recruitment is just about finding somebody who meets the criteria.”

The recruitment team needs to establish whether potential participants understand the practical requirements and can accommodate them.

For less demanding studies, the eligible population and the population able and willing to participate may be relatively close in size. For more demanding protocols, understanding this distinction becomes particularly important – participants need to consider how that time away will fit with work, family responsibilities and daily routines. For example, protocols may require long confinement periods, where participants must remain at the clinical unit for weeks. At Astrum’s unit, participants have been confined up to 3 consecutive weeks.

Explaining these requirements from the outset helps potential volunteers assess whether participation is manageable. As Susana Paixão notes: “Expectations need to be very clear from the beginning.”

Astrum’s recruitment team uses trial-specific call guidance to explain schedules and practical study information before the screening visit. The formal informed consent discussion remains with the research physician.

Using previous Phase I recruitment experience in planning

Recruitment planning draws on two complementary sources: the unit’s current volunteer database and the results of previous studies. The database indicates who can realistically be reached and re-engaged; completed studies provide reference points for achievable timelines and volumes.

Astrum database points to the depth of the available pool: of the volunteers who have already taken part at the unit, around 42% have participated at least twice (October 2026), indicating a recurring, re-engageable base. Previous studies speak to retention: non-adverse event (AE) dropout has stayed below 2% for studies requiring more than 10 days of consecutive confinement and below 4% for those running more than 100 days. Together, these give concrete anchors for recruitment and retention planning in more demanding Phase I studies.

Astrum Phase I Unit’s experience spans both intensive bursts and sustained output. On the intensive side, a recent study randomised 210 participants in just over 6 weeks; on the sustained side, the unit has averaged more than 100 participant randomisations per month for long periods. Together these show the team can hold recruitment pace across very different demands.

This performance rests on routine groundwork: keeping volunteer records current, assessing the available population early, and giving potential participants clear practical information about the study schedule and expected commitment before the screening visit. Together, these practices help the team identify potential participants and establish whether they can realistically commit to the study schedule.

Relevant comparisons include which criteria limited the available pool, how recruitment progressed under comparable confinement periods or visit schedules, and how participant availability shaped enrolment. Seasonality is another factor: recruitment behaviour has differed between summer and winter, and the team factors this into timeline planning.

As Susana Paixão summarises: “Experience does not remove the challenges of recruitment, but helps us anticipate them, plan for them and respond to them more effectively.”

Experience sharpens recruitment planning while recognising that clinical trial participation is always voluntary. Potential participants make an individual decision about whether to participate, and participants retain the right to withdraw. Experienced recruitment teams take these factors into account when developing realistic and flexible recruitment strategies.

Questions sponsors can ask a Phase I recruitment team

When evaluating a Phase I unit, sponsors can ask about database size alongside the information, experience and planning behind its recruitment estimates.

Useful questions include:

• How actively is your volunteer database maintained?
• How current is the data behind your feasibility assessments?
• Which protocol-specific characteristics can you screen for within your database?
• What experience does your team have with comparable populations or similarly demanding protocols?
• How early is the recruitment team involved in feasibility?
• How have you assessed the practical burden of our protocol?
• How do you distinguish an eligible population from a realistically recruitable one?
• What screen-failure rate do you assume for a protocol like ours, and how does that scale the number of volunteers you need to approach?
• How do other studies running at the unit affect volunteer availability for ours?

Recruitment feasibility is informed by data and experience

Up-to-date volunteer information, protocol-specific requirements and experience from comparable studies help a team estimate recruitment timelines. Each volunteer still needs to decide whether the study fits their circumstances. For sponsors, a useful feasibility discussion should explain how the recruitment estimate was reached, the information and experience supporting it, and how the recruitment strategy considers the practical requirements of the protocol.

That is where database size becomes recruitment intelligence.

How confident are you in your recruitment assumptions?

Speak with Astrum about recruitment feasibility for your next Phase I study.